HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase.

Abstract
Oxidatively modified LDL (LDLox) reduces the response of soluble guanylyl cyclase to nitrovasodilators. We now demonstrate that this desensitization can be antagonized by HDL. Similar to its protective effect against LDLox, HDL also inhibited the lysolecithin-induced desensitization of soluble guanylyl cyclase. Since the lysolecithin content of LDLox correlated with the amount of lysolecithin necessary to diminish stimulation of soluble guanylyl cyclase, our data support the hypothesis that lysolecithin may be responsible for the inhibitory effect of LDLox on smooth muscle relaxation and provide evidence that the antagonistic effect of HDL against desensitization of soluble guanylyl cyclase by atherogenic compounds could be responsible for the protective role of HDL in atherosclerosis.
AuthorsK Schmidt, P Klatt, W F Graier, G M Kostner, W R Kukovetz
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 182 Issue 1 Pg. 302-8 (Jan 15 1992) ISSN: 0006-291X [Print] United States
PMID1346247 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lipoproteins, HDL
  • Lipoproteins, HDL3
  • Lysophosphatidylcholines
  • Nitroso Compounds
  • Nitroprusside
  • Arachidonic Acid
  • Nitric Oxide
  • S-Nitrosoglutathione
  • Phospholipases A
  • Guanylate Cyclase
  • Glutathione
Topics
  • Animals
  • Arachidonic Acid (pharmacology)
  • Blood Platelets (enzymology)
  • Cattle
  • Cytosol (enzymology)
  • Glutathione (analogs & derivatives, pharmacology)
  • Guanylate Cyclase (blood)
  • Humans
  • Kinetics
  • Lipoproteins, HDL (antagonists & inhibitors, blood, isolation & purification, pharmacology)
  • Lipoproteins, HDL3
  • Lysophosphatidylcholines (pharmacology)
  • Nitric Oxide (pharmacology)
  • Nitroprusside (pharmacology)
  • Nitroso Compounds (pharmacology)
  • Phospholipases A (metabolism, pharmacology)
  • S-Nitrosoglutathione

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: